{"id":25757,"date":"2025-11-26T05:35:57","date_gmt":"2025-11-26T05:35:57","guid":{"rendered":"https:\/\/inderocro.com\/?post_type=podcast&#038;p=25757"},"modified":"2026-02-23T09:53:57","modified_gmt":"2026-02-23T14:53:57","slug":"clinical-trials-across-asia","status":"publish","type":"podcast","link":"https:\/\/inderocro.com\/fr\/podcast\/clinical-trials-across-asia\/","title":{"rendered":"Episode 36: Siow Bee Seu &#8211; Clinical Trials Across Asia Pacific"},"content":{"rendered":"<p><iframe src=\"https:\/\/w.soundcloud.com\/player\/?url=https%3A\/\/api.soundcloud.com\/tracks\/soundcloud%3Atracks%3A2218133342%3Fsecret_token%3Ds-24EzEckRlqY&amp;color=%23ff5500&amp;auto_play=false&amp;hide_related=false&amp;show_comments=true&amp;show_user=true&amp;show_reposts=false&amp;show_teaser=true\" width=\"100%\" height=\"166\" frameborder=\"no\" scrolling=\"no\"><\/iframe><\/p>\n<p><b><span data-contrast=\"auto\">Resources:<\/span><\/b><span data-ccp-props=\"{&quot;335559739&quot;:0}\">\u00a0<\/span><\/p>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"1\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"1\" data-aria-level=\"1\"><a href=\"mailto:info@inderocro.com\" target=\"_blank\" rel=\"noopener\">info@inderocro.com<\/a><\/li>\n<\/ul>\n<p><span data-ccp-props=\"{}\"> <img fetchpriority=\"high\" decoding=\"async\" class=\"alignnone wp-image-25770 \" src=\"https:\/\/inderocro.com\/wp-content\/uploads\/2025\/11\/Episode-36-Siow-Bee-1-1024x1024.png\" alt=\"\" width=\"552\" height=\"552\" srcset=\"https:\/\/inderocro.com\/wp-content\/uploads\/2025\/11\/Episode-36-Siow-Bee-1-1024x1024.png 1024w, https:\/\/inderocro.com\/wp-content\/uploads\/2025\/11\/Episode-36-Siow-Bee-1-300x300.png 300w, https:\/\/inderocro.com\/wp-content\/uploads\/2025\/11\/Episode-36-Siow-Bee-1-150x150.png 150w, https:\/\/inderocro.com\/wp-content\/uploads\/2025\/11\/Episode-36-Siow-Bee-1-768x768.png 768w, https:\/\/inderocro.com\/wp-content\/uploads\/2025\/11\/Episode-36-Siow-Bee-1.png 1200w\" sizes=\"(max-width: 552px) 100vw, 552px\" \/><\/span><\/p>\n<p><span data-contrast=\"auto\">Siow Bee Seu, Director of Clinical Operations for APAC at Indero, shares her insights in this episode, drawing on nearly 20 years of experience in clinical research across the APAC region. She brings expertise in project operations, regulatory strategy, and team management throughout diverse APAC markets. <\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">The discussion focuses on three key areas:\u00a0<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<ol>\n<li><span data-contrast=\"auto\">The Strategic Relevance of the APAC Region in Clinical Trials\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<li><span data-contrast=\"auto\">Adapting Clinical Trial Strategies to Country-Specific Contexts\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<li><span data-contrast=\"auto\">Managing Operational and Regulatory Nuances Across APAC<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<\/ol>\n<h2><strong>APAC\u2019s Role in Today\u2019s Clinical Trial Strategy\u00a0\u00a0<\/strong><\/h2>\n<p><span data-contrast=\"auto\">The APAC region is home to a large and diverse population, including India and China, 2 of the world\u2019s most populous countries, each projected to exceed 1.4 billion people in 2025. The region offers a mix of high- and low-cost countries, with several governments providing incentives that enhance cost-effectiveness in clinical trial execution.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Healthcare infrastructure, site capabilities, and experienced staff in countries such as Australia, Hong Kong, New Zealand, South Korea, and Singapore contribute to shorter startup timelines. In addition, countries like China, Malaysia, and South Korea have demonstrated strong recruitment performance, often enrolling the first patient or becoming top recruiters regionally and globally.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Government support and increased R&amp;D investment continue to grow across APAC, helping reduce operational costs. There is also a noticeable shift from late phase to early phase capabilities, particularly in China and Malaysia, where investment in Phase I facilities is expanding. Countries such as China, India, and Japan remain key contributors to high-volume late phase trials, especially in oncology, cardiovascular, renal, and metabolic indications.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Innovation and biotech activity have increased significantly in China, Japan, and South Korea, with decentralized clinical trial (DCT) models and AI-driven trial design gaining traction over the past 5 years.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<h2><strong>Selecting the Right Countries for Each Trial Phase\u00a0<\/strong><\/h2>\n<h3><strong>Early Phase Trials\u00a0<\/strong><\/h3>\n<p><span data-contrast=\"auto\">Country selection for early phase trials depends on several factors, including startup and recruitment timelines, patient prevalence, trial design (e.g., first-in-human or healthy volunteer studies), and regulatory and marketing strategies.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Australia and New Zealand are preferred destinations for early phase trials due to their streamlined regulatory frameworks. In Australia, most trials can be submitted under the Clinical Trial Notification (CTN) scheme, which simplifies the process. For high-risk investigational products, such as class 4 biologics involving human or animal cells, the Clinical Trial Approval (CTA) scheme is used. Both countries offer well-established phase I units, often in private settings, which support rapid startup and high-quality execution.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">South Korea presents a highly efficient environment for all phases. Early-phase trials in particular are supported by a streamlined regulatory process that allows for rapid IND and IRB approvals. The country has over 170 certified trial sites and is known for generating high-quality data aligned with global standards. A centralized healthcare system and strong public health literacy contribute to efficient patient recruitment and retention. Government investment further enhances its appeal.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">China is increasingly active in early phase trials, particularly among local biotech and pharmaceutical companies. The country offers advantages in cost, recruitment speed, and alignment with local marketing strategies. Additional countries such as Japan, Singapore, Taiwan, and Malaysia are also expanding their early phase capabilities.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<h3><strong>Late Phase Trials\u00a0<\/strong><\/h3>\n<p><span data-contrast=\"auto\">Japan is a strategic location for late phase trials due to its large and aging population, which is ideal for studies in oncology, cardiovascular, and neurodegenerative diseases. The Pharmaceuticals and Medical Devices Agency (PMDA) offers regulatory flexibility through early consultation and accelerated pathways. Japan is recognized for its rigorous compliance and high data quality, making its trial results highly credible and often essential for global regulatory submissions, particularly in multi-regional clinical trials (MRCTs). Regulatory requirements often mandate the inclusion of Japanese patient populations, making Japan a key destination for global sponsors.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><b><span data-contrast=\"auto\">As we conclude another illuminating episode of Phase Forward, we find ourselves at the crossroads of science and progress. Remember that behind the jargon and statistics, lies stories of unwavering commitment, meticulous observation, and the pursuit of evidence that shapes our understanding of health and disease. Stay at the forefront of knowledge and innovation and follow Phase Forward on your preferred platform. My name is Valerie Coveney. Thank you for joining us. Until next time.<\/span><\/b><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Resources:\u00a0 info@inderocro.com Siow Bee Seu, Director of Clinical Operations for APAC at Indero, shares her insights in this episode, drawing on nearly 20 years of experience in clinical research across the APAC region. She brings expertise in project operations, regulatory strategy, and team management throughout diverse APAC markets. \u00a0 The discussion focuses on three key [&hellip;]<\/p>\n","protected":false},"featured_media":16950,"parent":0,"template":"","meta":{"_acf_changed":false,"inline_featured_image":false},"podcast-category":[213],"class_list":["post-25757","podcast","type-podcast","status-publish","has-post-thumbnail","hentry","podcast-category-season-4"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Episode 36: Siow Bee Seu - Clinical Trials Across Asia Pacific | Indero<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/inderocro.com\/fr\/podcast\/clinical-trials-across-asia\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Beyond the Checklist: Elevating Clinical Research Associate Oversight for Quality and Impact\" \/>\n<meta property=\"og:description\" content=\"Explore our recent discussion on Beyond the Checklist: Elevating Clinical Research Associate Oversight for Quality and Impact, featuring Isabel Dorion, Senior Director of Clinical Operations at Indero.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/inderocro.com\/fr\/podcast\/clinical-trials-across-asia\/\" \/>\n<meta property=\"og:site_name\" content=\"Indero\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-23T14:53:57+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Beyond the Checklist: Elevating Clinical Research Associate Oversight for Quality and Impact\" \/>\n<meta name=\"twitter:description\" content=\"Explore our recent discussion on Beyond the Checklist: Elevating Clinical Research Associate Oversight for Quality and Impact, featuring Isabel Dorion, Senior Director of Clinical Operations at Indero.\" \/>\n<meta name=\"twitter:site\" content=\"@Innovaderm_\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/inderocro.com\/fr\/podcast\/clinical-trials-across-asia\/\",\"url\":\"https:\/\/inderocro.com\/fr\/podcast\/clinical-trials-across-asia\/\",\"name\":\"Episode 36: Siow Bee Seu - Clinical Trials Across Asia Pacific | Indero\",\"isPartOf\":{\"@id\":\"https:\/\/inderocro.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/inderocro.com\/fr\/podcast\/clinical-trials-across-asia\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/inderocro.com\/fr\/podcast\/clinical-trials-across-asia\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/inderocro.com\/wp-content\/uploads\/2025\/03\/PHASE-FORWARD.webp\",\"datePublished\":\"2025-11-26T05:35:57+00:00\",\"dateModified\":\"2026-02-23T14:53:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/inderocro.com\/fr\/podcast\/clinical-trials-across-asia\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/inderocro.com\/fr\/podcast\/clinical-trials-across-asia\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/inderocro.com\/fr\/podcast\/clinical-trials-across-asia\/#primaryimage\",\"url\":\"https:\/\/inderocro.com\/wp-content\/uploads\/2025\/03\/PHASE-FORWARD.webp\",\"contentUrl\":\"https:\/\/inderocro.com\/wp-content\/uploads\/2025\/03\/PHASE-FORWARD.webp\",\"width\":682,\"height\":474,\"caption\":\"Innovaderm to Indero\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/inderocro.com\/fr\/podcast\/clinical-trials-across-asia\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/inderocro.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Podcast\",\"item\":\"https:\/\/inderocro.com\/fr\/podcast-archive\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Episode 36: Siow Bee Seu &#8211; Clinical Trials Across Asia Pacific\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/inderocro.com\/fr\/#website\",\"url\":\"https:\/\/inderocro.com\/fr\/\",\"name\":\"Indero\",\"description\":\"Indero\",\"publisher\":{\"@id\":\"https:\/\/inderocro.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/inderocro.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/inderocro.com\/fr\/#organization\",\"name\":\"Indero\",\"url\":\"https:\/\/inderocro.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/inderocro.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/inderocro.com\/wp-content\/uploads\/2025\/06\/Indero_logos.svg\",\"contentUrl\":\"https:\/\/inderocro.com\/wp-content\/uploads\/2025\/06\/Indero_logos.svg\",\"width\":278,\"height\":75,\"caption\":\"Indero\"},\"image\":{\"@id\":\"https:\/\/inderocro.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/Innovaderm_\",\"https:\/\/www.linkedin.com\/company\/innovaderm-research-inc-\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Episode 36: Siow Bee Seu - Clinical Trials Across Asia Pacific | Indero","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/inderocro.com\/fr\/podcast\/clinical-trials-across-asia\/","og_locale":"fr_FR","og_type":"article","og_title":"Beyond the Checklist: Elevating Clinical Research Associate Oversight for Quality and Impact","og_description":"Explore our recent discussion on Beyond the Checklist: Elevating Clinical Research Associate Oversight for Quality and Impact, featuring Isabel Dorion, Senior Director of Clinical Operations at Indero.","og_url":"https:\/\/inderocro.com\/fr\/podcast\/clinical-trials-across-asia\/","og_site_name":"Indero","article_modified_time":"2026-02-23T14:53:57+00:00","twitter_card":"summary_large_image","twitter_title":"Beyond the Checklist: Elevating Clinical Research Associate Oversight for Quality and Impact","twitter_description":"Explore our recent discussion on Beyond the Checklist: Elevating Clinical Research Associate Oversight for Quality and Impact, featuring Isabel Dorion, Senior Director of Clinical Operations at Indero.","twitter_site":"@Innovaderm_","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/inderocro.com\/fr\/podcast\/clinical-trials-across-asia\/","url":"https:\/\/inderocro.com\/fr\/podcast\/clinical-trials-across-asia\/","name":"Episode 36: Siow Bee Seu - Clinical Trials Across Asia Pacific | Indero","isPartOf":{"@id":"https:\/\/inderocro.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/inderocro.com\/fr\/podcast\/clinical-trials-across-asia\/#primaryimage"},"image":{"@id":"https:\/\/inderocro.com\/fr\/podcast\/clinical-trials-across-asia\/#primaryimage"},"thumbnailUrl":"https:\/\/inderocro.com\/wp-content\/uploads\/2025\/03\/PHASE-FORWARD.webp","datePublished":"2025-11-26T05:35:57+00:00","dateModified":"2026-02-23T14:53:57+00:00","breadcrumb":{"@id":"https:\/\/inderocro.com\/fr\/podcast\/clinical-trials-across-asia\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/inderocro.com\/fr\/podcast\/clinical-trials-across-asia\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/inderocro.com\/fr\/podcast\/clinical-trials-across-asia\/#primaryimage","url":"https:\/\/inderocro.com\/wp-content\/uploads\/2025\/03\/PHASE-FORWARD.webp","contentUrl":"https:\/\/inderocro.com\/wp-content\/uploads\/2025\/03\/PHASE-FORWARD.webp","width":682,"height":474,"caption":"Innovaderm to Indero"},{"@type":"BreadcrumbList","@id":"https:\/\/inderocro.com\/fr\/podcast\/clinical-trials-across-asia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/inderocro.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Podcast","item":"https:\/\/inderocro.com\/fr\/podcast-archive\/"},{"@type":"ListItem","position":3,"name":"Episode 36: Siow Bee Seu &#8211; Clinical Trials Across Asia Pacific"}]},{"@type":"WebSite","@id":"https:\/\/inderocro.com\/fr\/#website","url":"https:\/\/inderocro.com\/fr\/","name":"Indero","description":"Indero","publisher":{"@id":"https:\/\/inderocro.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/inderocro.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/inderocro.com\/fr\/#organization","name":"Indero","url":"https:\/\/inderocro.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/inderocro.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/inderocro.com\/wp-content\/uploads\/2025\/06\/Indero_logos.svg","contentUrl":"https:\/\/inderocro.com\/wp-content\/uploads\/2025\/06\/Indero_logos.svg","width":278,"height":75,"caption":"Indero"},"image":{"@id":"https:\/\/inderocro.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/Innovaderm_","https:\/\/www.linkedin.com\/company\/innovaderm-research-inc-\/"]}]}},"_links":{"self":[{"href":"https:\/\/inderocro.com\/fr\/wp-json\/wp\/v2\/podcast\/25757","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/inderocro.com\/fr\/wp-json\/wp\/v2\/podcast"}],"about":[{"href":"https:\/\/inderocro.com\/fr\/wp-json\/wp\/v2\/types\/podcast"}],"version-history":[{"count":0,"href":"https:\/\/inderocro.com\/fr\/wp-json\/wp\/v2\/podcast\/25757\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/inderocro.com\/fr\/wp-json\/wp\/v2\/media\/16950"}],"wp:attachment":[{"href":"https:\/\/inderocro.com\/fr\/wp-json\/wp\/v2\/media?parent=25757"}],"wp:term":[{"taxonomy":"podcast-category","embeddable":true,"href":"https:\/\/inderocro.com\/fr\/wp-json\/wp\/v2\/podcast-category?post=25757"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}